2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: Cognitive outcomes of STN-DBS in GBA mutation carriers with PD

G. Pal, E. Hill, T. Foltynie, V. Lythe, R. Alcalay, P. Garcia, K. Marder, R. Saunders-Pullman, S. Bressman, J. Aasly, B. Ouyang, Y. Liu, S. Anderson, B. Bernard, L. Verhagen (Chicago, IL, USA)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Cognitive profile of degenerative parkinsonian syndromes in the French West Indies and relationship with eye movements recordings

A. Petit, A. Lackmy, R. Edragas, S. Belson, A. Mongis-Marlin, C. Stattner, F. Triboulet, G. Lepage, B. Tressieres, B. Gaymard, A. Lannuzel (Fort de France, Martinique)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Cognitive Profile of Patients with Parkinson´s Disease and Subthalamic Nucleus Deep Brain Stimulation

E. Barbosa, J. Santos, H. Fichman (Rio de Janeiro, Brazil)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil

N. Sousa, A. Neri, I. Brandi, S. Brucki (Salvador, Brazil)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Combined STN and NBM DBS in PD and mild to moderate Parkinson’s dementia

R. Nickl, P. Fricke, P. Capetian, M. Reich, J. Krapp, V. Sturm, J. Volkmann, C. Matthies (Wuerzburg, Germany)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Comparing motor and neuropathological features of Parkinson’s disease dementia and dementia with Lewy bodies

D. Hansen, T. Lashley, J. Holton, T. Warner (London, United Kingdom)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)

A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Comparison of autonomic symptoms on Parkinson’s disease and essential tremor with SCOPA-AUT

J. Gonzalez (Lima, Peru)

Non-Motor Symptoms · Agora 3 West, Level 3